Loading company details...
Beta
Latest Form 4 (Jan 23, 2026): Jonathan Violin (Director): Disposition to Issuer of 263,321 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 23, 2026 | Jonathan Violin | Disposition to Issuer | 263,321 | n/a |
| Jan 23, 2026 | Christopher Morabito, Chief Medical Officer | Disposition to Issuer | 80,000 | n/a |
| Jan 23, 2026 | Jill C. Milne, CEO and President | Disposition to Issuer | 4,377 | n/a |
| Jan 23, 2026 | Andrea Matthews, Chief Business Officer | Disposition to Issuer | 32,812 | n/a |
| Jan 23, 2026 | Anthony Gregg Lapointe | Disposition to Issuer | 16,666 | n/a |
| Jan 23, 2026 | Andrew Komjathy, Chief Commercial Officer | Disposition to Issuer | 10 | n/a |
| Jan 23, 2026 | Michael D. Kishbauch | Disposition to Issuer | 16,666 | n/a |
| Jan 23, 2026 | Benjamin Harshbarger, Chief Legal Officer | Disposition to Issuer | 33,333 | n/a |
| Jan 23, 2026 | Hugh M. Cole | Disposition to Issuer | 16,666 | n/a |
| Jan 23, 2026 | Noah Clauser, Chief Financial Officer | Disposition to Issuer | 55,000 | n/a |